Berberine synergistically decreases FcεRI signaling by reducing phosphorylated Syk and lowers IgE generation from plasma cells, providing an interesting direction for further investigation into its potential as a therapeutic agent for allergic diseases. This evidence concerns the gene FCER1A and allergic disease.